So you want to resell research peptides.
Everyone sees the margin. Almost nobody sees the clock ticking on the grey market. Seven questions - seventy-five seconds - and you'll know whether this window fits you, or whether you're already late.
Did you know some vials leave the factory at ±$3 - and list at $50+ in the U.S.?
That gap is the entire business model. But margin on paper ≠ margin in the bank - third-party testing, lyophilization quality, payment processing and chargebacks all take their cut. Slide the numbers yourself:
*Hypothetical illustration at ~$3 landed cost, before COAs, fulfillment, processing fees and taxes. Not an income claim.
Did you know the giants hate waiting - and while they wait on GLP-1 exclusivity, they're pushing to shut the grey market down?
Big pharma's GLP-1 blockbusters are worth tens of billions - and the players holding them do not want unregulated resellers riding their demand curve while exclusivity battles play out. So the pressure moves down the chain: FDA warning letters, compounding-pharmacy crackdowns, payment processors dropping peptide merchants, ad platforms banning the keywords.
Every gold rush ends the same way - the money is made before the sheriff arrives. The people who built stores, supplier relationships and buyer lists before the squeeze are the ones who get acquired, pivot, or cash out. The ones who arrive after get seized domains.
Do you know the label this entire industry stands on?
The moment a vial is marketed for human use, you're not a reseller anymore - you're an unlicensed drug distributor. The operators who survive treat compliance as product: research-only labeling, no dosage claims, no before/after photos, no human-use language anywhere - site, ads, emails, DMs.
Your real product isn't the peptide. It's the paperwork: batch-specific COAs, third-party HPLC/mass-spec results, and a paper trail from factory to shelf. In a grey market, proof is the brand.
Did you know that 49 out of 50 "wholesale factories" that surface in a Google search are scammers?
Scammers exploit exactly one thing: an unregulated grey market full of buyers holding no information. Polished websites, fake wholesale representatives, stolen lab reports. Meanwhile the real factories barely know what a Google results page is - no SEO, no English keywords, no ads. You will not keyword-search your way to a synthesis plant.
The contacts you meet fall into five types: scammers posing as factories · middlemen selling a verified factory’s output under its identity · middlemen who may offer cheaper sugar powder for sale under your own name · real factories (some lowered their minimum to 3 kits) · and trading houses linked to science centers. Learning to tell them apart matters more than the first quoted price.
A "factory" sends you a Janoshik COA and the QR code actually resolves. Safe to wire the money?
Open Janoshik's public database and you'll find pages of results booked under throwaway customer names - JD, JP, MJ, OK, AAA. Your "factory" points at one and shrugs: that's me, I just keep a low profile. There is no way to prove it isn't. And even a 100% genuine report answers only one question: what was inside the one vial that got mailed to the lab - not the batch about to land at your door.
Add the rest of the COA deception playbook - photoshopped PDFs, cloned QR codes, one good batch's report reused for a year, expired lot numbers - and the rule writes itself: trust only the test you or your community commissioned, tied to the lot in your hand.
Have you ever actually sold anything online?
Peptide resale is not a "build a store and they will come" game - ad platforms ban the niche on sight, so distribution is earned through communities, email lists, SEO and word of mouth. Operators with any selling scar tissue ramp in weeks; total beginners should budget months to learn the channel game.
Did you know you can end up blacklisted by payment merchants - before your store sells a single vial?
The same pharma giants squeezing the grey market also hold the line at the biggest merchant services: Stripe, PayPal and Square ban peptide sellers on sight, terminate without appeal, and can park your money for 90-180 days. Worse - a termination can land you on the industry MATCH list, a shared blacklist that makes mainstream providers decline you on application, sometimes for years.
So veterans keep a deliberate distance from the popular processors and run high-risk merchant accounts, eCheck/ACH and self-hosted crypto instead. In the playbook PDF we shortlisted vetted high-risk merchant providers that actually board this niche - pick yours there instead of learning the MATCH list firsthand.
You're built for the window.
You know the spread and you can smell a borrowed COA. Start lean, validate fast, and let the margin fund the catalog.
Inside the playbook: the grey-market map · the margin math from a $3 vial to a $50+ listing · the high-risk merchant shortlist · the COA verification kit · printer and packaging supplier tables.THE VENDOR LISTResellers, middlemen and factory-side sources in one table, with independent field notes on each.
Compiled from open sources and community field reporting. One document instead of six months of expensive mistakes.
Read online or download the PDF in your selected language. No email required.
Live vendor database, updated as the market moves → @greylocator_bot
Educational briefing only. Nothing here is legal, medical or financial advice, and no income is promised or implied. Peptides discussed are research chemicals, not approved for human consumption; regulations vary by jurisdiction and change fast - consult a qualified attorney before selling anything.